Long Position on GMED @ $23.00 on 2/7/2014 (Momentum)

Globus Medical (GMED) is a medical device company.

The firm focuses on the design, development, and commercialization of products that promote healing in patients with spine disorders. It offers approximately 100 innovative fusion and disruptive technology products that address an array of spinal pathologies, anatomies, and surgical approaches.

The company’s innovative fusion products are used in cervical, thoracolumbar, sacral, and interbody/corpectomy fusion procedures to treat degenerative, deformity, tumor, and trauma conditions. Its disruptive technology products provide material improvements to fusion procedures, such as minimally invasive surgical techniques, as well as new treatment alternatives, which include motion preservation technologies, such as dynamic stabilization, total disc replacement and interspinous process spacer products, and advanced biomaterials technologies.

The company’s products under clinical development include SECURE-C Cervical Artificial Disc, an artificial disc designed to alleviate pain and preserve motion in patients with symptomatic cervical disc disease; ACADIA Facet Replacement System, which allows for an anatomic reconstruction of the facet joint after the degenerated facet is decompressed and removed; and TRIUMPH Lumbar Disc that is used in the treatment of lumbar degenerative disc disease. Globus Medical, Inc. sells its implants and related disposables primarily to hospitals.

Shares have formed a bullish "flag" after the firm reported its prelimiary quarterly results and guided higher. Furthermore, Merrill Lynch name the stock as one of the best stocks for 2014. Shares are expected to head higher out of this formation.

52-Week Trading Range: $12.50 - $23.95

Entry Point: $23.00

Stop Loss: $21.85

Target Price: $25.30

Updates

3/5/2014 9:44:16 AM

GMED reached our target. Positon closed at $25.40

Position closed on 3/5/2014 at price of $25.50 with a 10.87% gain in 26 days.

Back to Portfolio